Singapore markets closed
Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
38,763.95 +215.94 (+0.56%) CMC Crypto 200
802.76 +11.20 (+1.41%)
Aadi Bioscience, Inc. (AADI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 122.38M |
| Enterprise value | 4.42M |
| Trailing P/E | 1.89 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 5.77 |
| Price/book (mrq) | 1.04 |
| Enterprise value/revenue | 0.19 |
| Enterprise value/EBITDA | -0.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.19 |
| 52-week change 3 | -60.72% |
| S&P500 52-week change 3 | 14.23% |
| 52-week high 3 | 13.6000 |
| 52-week low 3 | 3.8800 |
| 50-day moving average 3 | 4.5720 |
| 200-day moving average 3 | 6.6425 |
Share statistics
| Avg vol (3-month) 3 | 111.12k |
| Avg vol (10-day) 3 | 112.95k |
| Shares outstanding 5 | 24.53M |
| Implied shares outstanding 6 | 24.53M |
| Float 8 | 16.39M |
| % held by insiders 1 | 12.51% |
| % held by institutions 1 | 60.70% |
| Shares short (14 Nov 2023) 4 | 743.74k |
| Short ratio (14 Nov 2023) 4 | 8.15 |
| Short % of float (14 Nov 2023) 4 | 4.61% |
| Short % of shares outstanding (14 Nov 2023) 4 | 3.03% |
| Shares short (prior month 12 Oct 2023) 4 | 801.28k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 26 Aug 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | -272.67% |
| Operating margin (ttm) | -299.53% |
Management effectiveness
| Return on assets (ttm) | -26.10% |
| Return on equity (ttm) | -44.14% |
Income statement
| Revenue (ttm) | 23.25M |
| Revenue per share (ttm) | 0.87 |
| Quarterly revenue growth (yoy) | 40.40% |
| Gross profit (ttm) | -18.78M |
| EBITDA | -69.52M |
| Net income avi to common (ttm) | -63.41M |
| Diluted EPS (ttm) | -2.3200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 119.33M |
| Total cash per share (mrq) | 4.87 |
| Total debt (mrq) | 1.37M |
| Total debt/equity (mrq) | 1.16% |
| Current ratio (mrq) | 6.48 |
| Book value per share (mrq) | 4.82 |
Cash flow statement
| Operating cash flow (ttm) | -61.33M |
| Levered free cash flow (ttm) | -39.17M |
© 2023 Yahoo. All rights reserved.